The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

13 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Structural Evolution and Translational Potential for Agonists and Antagonists of Endosomal Toll-like Receptors.EBI
Csir-Indian Institute of Chemical Biology
Fascinating Transformation of SAM-Competitive Protein Methyltransferase Inhibitors from Nucleoside Analogues to Non-Nucleoside Analogues.EBI
Csir-Indian Institute of Chemical Biology
Development, Optimization, and In Vivo Validation of New Imidazopyridine Chemotypes as Dual TLR7/TLR9 Antagonists through Activity-Directed Sequential Incorporation of Relevant Structural Subunits.EBI
Csir-Indian Institute of Chemical Biology
Topoisomerase I inhibitors: Challenges, progress and the road ahead.EBI
Csir-Indian Institute of Chemical Biology
Systematic Optimization of Potent and Orally Bioavailable Purine Scaffold as a Dual Inhibitor of Toll-Like Receptors 7 and 9.EBI
Csir-Indian Institute of Chemical Biology
Synthesis and characterization of new potent TLR7 antagonists based on analysis of the binding mode using biomolecular simulations.EBI
Csir-Indian Institute of Chemical Biology
Development of a metabolically stable topoisomerase I poison as anticancer agent.EBI
Csir-Indian Institute of Chemical Biology
A Chemical Switch for Transforming a Purine Agonist for Toll-like Receptor 7 to a Clinically Relevant Antagonist.EBI
Csir-Indian Institute of Chemical Biology
Discovery and Mechanistic Study of Tailor-Made Quinoline Derivatives as Topoisomerase 1 Poison with Potent Anticancer Activity.EBI
Csir-Indian Institute of Chemical Biology
Activity-guided development of potent and selective toll-like receptor 9 antagonists.EBI
Csir-Indian Institute of Chemical Biology
Design and development of benzoxazole derivatives with toll-like receptor 9 antagonism.EBI
Csir-Indian Institute of Chemical Biology
Discovery of two classes of potent glycomimetic inhibitors of Pseudomonas aeruginosa LecB with distinct binding modes.BDB
University of Konstanz
Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonistsBDB
Bristol-Myers Squibb